<?xml version="1.0" encoding="UTF-8"?>
<p>In the 
 <italic>New England Journal of Medicine</italic>, Vaduganathan 
 <italic>et al</italic>. discuss the potential beneficial effects of ACEIs and ARBs in COVID-19.
 <xref rid="pvaa053-B9" ref-type="bibr">
  <sup>9</sup>
 </xref> They state that SARS-CoV-2 appears to down-regulate ACE2 functions and that it has been postulated that ACE2 deficiency induces unabated AngII activity, which may be in part responsible for organ njury in COVID-19.
</p>
